Analysts Viewpoint
Investing in Enanta Pharmaceuticals Inc (ENTA) Is Getting More Attractive
Enanta Pharmaceuticals Inc’s filing revealed that its Chief Product Strategy Officer Kieffer Tara Lynn unloaded Company’s shares for reported $18401.0
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.